secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oaktree Acquisition Corp. III Life Sciences (OACC)
CIK:        0002029769
Form:       8-K
Filed at:   2025-01-07T23:59:59+00:00
Accession:  0001193125-25-002863
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Oaktree Acquisition Corp III board changes: Frank resigns, Kumar chairman, Pardesi appointed director
--------------------------------------------------------------------------------

- John Frank resigned from the board effective Jan 6, 2025, not due to any disagreement with the company.
- Aman Kumar, an existing director, was appointed as the new chairman of the board.
- CEO Zaid Pardesi was appointed as a Class III director, term expiring at third annual shareholder meeting.
- Pardesi and Kumar have material interests in the Sponsor Oaktree Acquisition Holdings III LS, as previously disclosed in the IPO prospectus.
- No arrangements or family relationships exist between Pardesi and other directors or executive officers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2029769/000119312525002863/0001193125-25-002863-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2029769/000119312525002863/d920585d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-002863

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer